Ultragenyx

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$37.02-$60.37
Market Cap
$4.2B
Shares Short
3M

Financials

See more
Revenue (12 Mos)
$522.7M
Revenue Growth (YoY)
42.3%
Gross Profit (12 Mos)
-$370.7M
Diluted EPS
-$6.35

News

See more

Yahoo Finance • 13 days ago

Suspect arrested after stabbing spree in downtown Seattle

Yahoo Finance • 6 months ago

Ultragenyx Announces Positive Top-Line Results from Phase 3 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)

Yahoo Finance • 6 months ago

Ultragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks' Cells

Yahoo Finance • 7 months ago

Ultragenyx Announces Completion of Enrollment in Phase 3 Orbit and Cosmic Studies Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)

About

CEO
Dr. Emil D. Kakkis M.D., Ph.D.
CFO
Mr. Howard Horn
Address
60 Leveroni Court, Novato, CA, United States, 94949
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
1,276